GeneDx Holdings Corp’s recent filing unveils that its Director Meister Keith A. acquired Company’s shares for reported $3.01 million on May 14 ’25. In the deal valued at $60.16 per share,50,000 shares were bought. As a result of this transaction, Meister Keith A. now holds 3,058,629 shares worth roughly $217.22 million.
Then, Meister Keith A. bought 100,000 shares, generating $5,600,994 in total proceeds. Upon buying the shares at $56.01, the Director now owns 3,008,629 shares.
Before that, Feeley Kevin sold 388 shares. GeneDx Holdings Corp shares valued at $43,879 were divested by the CHIEF FINANCIAL OFFICER at a price of $113.09 per share. As a result of the transaction, Feeley Kevin now holds 3,337 shares, worth roughly $0.24 million.
Guggenheim initiated its GeneDx Holdings Corp [WGS] rating to a Buy in a research note published on May 15, 2025; the price target was $88. A number of analysts have revised their coverage, including Jefferies’s analysts, who increased its forecast for the stock in early May from “a Hold” to “a Buy”. Wells Fargo began covering WGS with “an Equal weight” recommendation on August 28, 2024. Craig Hallum started covering the stock on July 10, 2024. It rated WGS as “a Buy”.
Price Performance Review of WGS
On Monday, GeneDx Holdings Corp [NASDAQ:WGS] saw its stock jump 3.97% to $71.02. Over the last five days, the stock has gained 20.37%. GeneDx Holdings Corp shares have fallen nearly -7.60% since the year began. Nevertheless, the stocks have risen 235.63% over the past one year.
How much short interest is there in GeneDx Holdings Corp?
A steep rise in short interest was recorded in GeneDx Holdings Corp stocks on 2025-04-30, growing by 0.81 million shares to a total of 3.57 million shares. Yahoo Finance data shows the prior-month short interest on 2025-03-31 was 2.76 million shares. There was a rise of 22.7%, which implies that there is a positive sentiment for the stock.
